Abstract
Background
Pallidal deep brain stimulation (GPi-DBS) is effective for treating myoclonus and dystonia caused by SGCE mutations (DYT-SGCE, DYT11). However, it is unknown whether GPi-DBS is effective for the treatment of myoclonus-dystonia which is not associated with the SGCE gene mutations. In this study, we investigated the efficacy of GPi-DBS in treating myoclonus-dystonia in SGCE mutation-negative cases.
Methods
Three patients with myoclonus-dystonia without SGCE mutations who underwent GPi-DBS were evaluated preoperatively and 6 months postoperatively using the Unified Myoclonus Rating Scale (UMRS) and Fahn–Marsden Dystonia Rating Scale (FMDRS) for myoclonus and dystonia, respectively. In two of the three patients, myoclonus was more evident during action. Myoclonus was predominant at rest in the other patient, and he was unaware of his dystonia symptoms. The results were compared with those of the four DYT-SGCE cases.
Results
The mean UMRS score in patients with myoclonus-dystonia without SGCE mutations improved from 61.7 to 33.7 pre- and postoperatively, respectively, and the mean FMDRS score improved from 7.2 to 4.5. However, the degree of improvement in myoclonus-dystonia in patients without SGCE mutations was inferior to that in patients with DYT-SGCE (the UMRS score improved by 45% and 69%, respectively).
Conclusions
GPi-DBS is effective for treating myoclonus-dystonia in patients with and without SGCE mutations. GPi-DBS should be considered as a treatment option for myoclonus-dystonia without SGCE mutations.
Data availability statement
The data that support the fndings of this study are available from the corresponding author, [JI], upon reasonable request. The data are not publicly available due to [restrictions e.g. their containing information that could compromise the privacy of research participants].
References
Kosutzka Z, Tisch S, Bonnet C et al (2019) Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment. Mov Disord 34:87–94. https://doi.org/10.1002/mds.27474
Ramdhani RA, Frucht SJ, Behnegar A, Kopell BH (2016) Improvement of isolated myoclonus phenotype in myoclonus dystonia after pallidal deep brain stimulation. Tremor Other Hyperkinet Mov (N Y) 6:369. https://doi.org/10.7916/D8F47P0C
Besa Lehmann V, Rosenbaum M, Bulman DE, Read T, Verhagen Metman L (2020) A case report of myoclonus-dystonia with isolated myoclonus phenotype and novel mutation successfully treated with deep brain stimulation. Neurol Ther 9:187–191. https://doi.org/10.1007/s40120-020-00186-4
Wang X, Yu X (2021) Deep brain stimulation for myoclonus dystonia syndrome: a meta-analysis with individual patient data. Neurosurg Rev 44:451–462. https://doi.org/10.1007/s10143-019-01233-x
Tisch S (2022) Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and long term follow-up. Curr Opin Neurol 35:510–517. https://doi.org/10.1097/wco.0000000000001072
Tisch S, Kumar KR (2021) Pallidal deep brain stimulation for monogenic dystonia: the effect of gene on outcome. Front Neurol 11:630391. https://doi.org/10.3389/fneur.2020.630391
Sidiropoulos C, Mestre T, Hutchison W et al (2014) Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus. Parkinsonism Relat Disord 20:915–918. https://doi.org/10.1016/j.parkreldis.2014.04.017
Kim JH, Na YC, Lee WH et al (2014) Bilateral globus pallidus interna deep-brain stimulation in a patient with myoclonus-dystonia: a case report. Neuromodulation 17:724–728. https://doi.org/10.1111/ner.12162
Frucht SJ, Leurgans SE, Hallett M, Fahn S (2002) The unified myoclonus rating scale. Adv Neurol 89:361–376
Burke RE, Fahn S, Marsden CD et al (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73–77. https://doi.org/10.1212/wnl.35.1.73
Chandra V, Hilliard JD, Foote KD (2022) Deep brain stimulation for the treatment of tremor. J Neurol Sci 435:120190. https://doi.org/10.1016/j.jns.2022.120190
Martinez-Ramirez D, Hack N, Vasquez ML et al (2016) Deep brain stimulation in a case of mitochondrial disease. Mov Disord Clin Pract 3:139–145. https://doi.org/10.1002/mdc3.12241
Jones HF, Morales-Briceño H, Barwick K et al (2019) Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation. Mov Disord 34:1079–1080. https://doi.org/10.1002/mds.27708
Youn J, Slow E, Chen R, Lozano AM, Fasano A (2023) Pallidal deep brain stimulation for refractory celiac-related myoclonus. J Mov Disord 16:325–327. https://doi.org/10.14802/jmd.23006
Shpiner DS, Peabody TK, Luca CC, Jagid J, Moore H (2023) Deep brain stimulation for an unusual presentation of myoclonus dystonia associated with Russell-Silver syndrome. Tremor Other Hyperkinet Mov (N Y) 13:40. https://doi.org/10.5334/tohm.782
Liu JY, Ouyang Y, Lv H et al (2023) Deep brain stimulation for myoclonus in sialidosis I. Parkinsonism Relat Disord 111:105434. https://doi.org/10.1016/j.parkreldis.2023.105434
Kojovic M, Cordivari C, Bhatia K (2011) Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord 4:47–62. https://doi.org/10.1177/1756285610395653
Schirinzi T, Sciamanna G, Mercuri NB, Pisani A (2018) Dystonia as a network disorder: a concept in evolution. Curr Opin Neurol 31:498–503. https://doi.org/10.1097/WCO.0000000000000580
Hubsch C, Vidailhet M, Rivaud-Péchoux S et al (2011) Impaired saccadic adaptation in DYT11 dystonia. J Neurol Neurosurg Psychiatry 82:1103–1106. https://doi.org/10.1136/jnnp.2010.232793
Ikezawa J, Yokochi F, Okiyama R et al (2021) Is generalized and segmental dystonia accompanied by impairments in the dopaminergic system? Front Neurol 12:751434. https://doi.org/10.3389/fneur.2021.751434
Zech M, Jech R, Boesch S et al (2020) Monogenic variants in dystonia: an exome-wide sequencing study. Lancet Neurol 19:908–918. https://doi.org/10.1016/S1474-4422(20)30312-4
Acknowledgements
The authors would like to thank Dr. Makoto Taniguchi. As the head of the Department of Neurosurgery at Tokyo Metropolitan Neurological Hospital, he treated the patients. Unfortunately, he passed away in 2020. We are also grateful to the staff of the Neurology and Neurosurgery Departments of the Tokyo Metropolitan Neurological Hospital, who helped us with our practice. We would also like to express our deepest gratitude to Dr. Erika Abe of the National Hospital Organization Akita Hospital and Dr. Hiroyuki Akagawa of the Tokyo Women’s Medical University for conducting the SGCE gene test.
Funding
No specific funding was received for this work.
Author information
Authors and Affiliations
Contributions
Conception: JI and FY. Execution: JI, FY, RO, AI, TA, Tsutomu K, MT, AY, Takashi K, KW, and SK. Writing of the first draft: JI. Organization, review, and critique: JI, RO, AI, TA, MT, Tsutomu K, AY, Takashi K, KW, SK and KT.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflicts of interest associated with this manuscript. Unrelated to this work, JI and FY received grants from InSightec, Ltd., for a trial on focused ultrasound for Parkinson’s disease.
Ethical approval
Studies involving human participants were reviewed and approved by the Ethics Committee of Tokyo Metropolitan Neurological Hospital. We also confirm that patients provided written informed consent for the publication of their videos.
Consent to participate
Informed consent was obtained using the opt-out method.
Consent to publish
Written informed consent to release the video was obtained from the patients.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 5863 KB)
Rights and permissions
About this article
Cite this article
Ikezawa, J., Yokochi, F., Okiyama, R. et al. Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations. J Neurol (2024). https://doi.org/10.1007/s00415-024-12334-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00415-024-12334-z